Femasys Inc. Share Price
NASDAQ: FEMY | Micro CapFemasys Inc. Stock Performance
Femasys Inc. Share Price Chart
Femasys Inc. Quarterly Profit & Loss
All figures in USD
Femasys Inc. Annual Profit & Loss
All figures in USD
About Femasys Inc.
Femasys Inc., a biomedical company, develops therapeutic and diagnostic solutions to address unmet women healthcare needs in the United States and internationally. The company offers FemaSeed, an intratubal insemination solution; FemVue, a companion diagnostic for fallopian tube assessment through ultrasound; FemCerv, an endocervical tissue sampler for cervical cancer diagnosis; FemCath, a cornual balloon catheter for selective fallopian tube evaluation; and FemChec, a controlled contrast-generating device for fallopian tube diagnosis. It also develops FemBloc, a non-surgical permanent birth control solution. The company offers its products to reproductive endocrinologists, gynecological physicians, related healthcare professionals, and women's healthcare provider organizations. Femasys Inc. was incorporated in 2004 and is headquartered in Suwanee, Georgia.
Femasys Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Sep 2026 | $3.35 | $2.61 | -7.28% |
Aug 2026 | $2.95 | $2.81 | -4.09% |
Jul 2026 | $4.28 | $2.94 | -21.73% |
Jun 2026 | $0.37 | $3.75 | +900.00% |
May 2026 | $0.37 | $0.38 | +1.90% |
Apr 2026 | $0.44 | $0.37 | -12.80% |
Mar 2026 | $0.55 | $0.42 | -25.83% |
Feb 2026 | $0.53 | $0.57 | +5.18% |
Jan 2026 | $0.62 | $0.54 | -5.75% |
Dec 2025 | $0.95 | $0.57 | -44.00% |
Nov 2025 | $0.76 | $1.02 | +61.42% |
Oct 2025 | $0.35 | $0.64 | +79.89% |